Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ogura, Takashi"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 70
Tytuł:
A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.
Autorzy:
Okamoto M; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan. okamoto_.; Department of Respirology, NHO Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-0065, Japan. okamoto_.
Fujimoto K; Department of Radiology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.
Johkoh T; Department of Radiology, Kansai Rosai Hospital, Inabasou 3-1-69, Amagasaki, Hyogo, 660-0064, Japan.
Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga Medical School, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Sakamoto N; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Ogura T; Division of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Yokohama, Kanagawa-ku, Kanagawa, 236-0051, Japan.
Ikeda S; Division of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Yokohama, Kanagawa-ku, Kanagawa, 236-0051, Japan.
Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake, Seto, Aichi, 489-0065, Japan.
Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake, Seto, Aichi, 489-0065, Japan.
Komiya K; Respiratory Medicine and Infectious Diseases, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.
Umeki K; Department of Respiratory Medicine, Tenshindo Hetsugi Hospital, 5956 Nakahetsugi, Oita, 879-7761, Japan.
Nishikiori H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, South-1-West-16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan.
Tanino Y; Department of Pulmonary Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
Tsuda T; Kirigaoka Tsuda Hospital, 3-9-20 Kirigaoka, Kitakyushu, Fukuoka, 802-0052, Japan.
Arai N; Department of Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital, 825 Terunuma, Tokai-mura, Ibaraki, 319-1113, Japan.
Komatsu M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Sakamoto S; Department of Respiratory Medicine, Toho University Omori Medical Center, 6-11-1 Omorinishi, Tokyo, 143-8541, Japan.
Yatera K; Department of Respiratory Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Kitakyushu, Fukuoka, 807-8555, Japan.
Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nagasone-cho, Sakai, Osaka, 591-8555, Japan.
Miyazaki Y; Department of Respiratory Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo, 113-8510, Japan.
Hashimoto S; Department of Respiratory Medicine, Tenri Hospital, 200 Mishima-cho, Tenri, Nara, 632-8552, Japan.
Shimizu Y; Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi, 321-0293, Japan.
Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Ohnishi H; Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, 185-1 Kohasu, Nankoku, Kochi, 783-8505, Japan.
Handa T; Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Hattori N; Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Kishaba T; Department of Respiratory Medicine, Okinawa Chubu Hospital, 281 Miyazato, Uruma, Okinawa, 904-2293, Japan.
Kato M; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-8421, Japan.
Inomata M; Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Tokyo, 150-8935, Japan.
Ishii H; Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyouin, Chikushino, Fukuoka, 818-8502, Japan.
Hamada N; Department of Respiratory Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Fukuoka, 814-0180, Japan.
Konno S; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, N15W7 Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
Zaizen Y; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.
Azuma A; Respirology and Clinical Research Center, Mihara General Hospital and Nippon Medical School, Tokorozawa, Saitama, 359-0045, Japan.
Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Izuhara K; Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Hoshino T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 27; Vol. 13 (1), pp. 22977. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Periostin*
Idiopathic Pulmonary Fibrosis*/drug therapy
Humans ; Prospective Studies ; Vital Capacity ; Biomarkers ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study.
Autorzy:
Aoki A; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hara Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Fujii H; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Pulmonology, Yokohama Minami Kyousai Hospital, Yokohama, Japan.
Murohashi K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nagasawa R; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Tagami Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Enomoto T; Department of Respiratory Medicine, Ofuna Chuo Hospital, Kamakura, Japan.
Matsumoto Y; Department of Respiratory Medicine, Yamato Municipal Hospital, Yamato, Japan.
Masuda M; Department of Respiratory Medicine, Ofuna Chuo Hospital, Kamakura, Japan.; Department of Respiratory Medicine, Fujisawa City Hospital, Fujisawa, Japan.
Watanabe K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Horita N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kobayashi N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kudo M; Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Kaneko T; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 19; Vol. 18 (9), pp. e0291489. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/epidemiology
Aged ; Humans ; Antifibrotic Agents ; Comorbidity ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantitative Analysis for Lung Disease on Thin-Section CT.
Autorzy:
Iwasawa T; Department of Radiology, Kanagawa Cardiovascular & Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Matsushita S; Department of Radiology, Kanagawa Cardiovascular & Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Hirayama M; Department of Radiology, Kanagawa Cardiovascular & Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular & Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular & Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Sep 18; Vol. 13 (18). Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy.
Autorzy:
Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
Oda K; Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
Takizawa H; Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Miyamoto A; Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan.
Akagawa S; Department of Respiratory Medicine, National Hospital Organization Tokyo Hospital, Tokyo, Japan.
Hashimoto S; Department of Respiratory Medicine, Tenri Hospital, Tenri, Nara, Japan.
Kishaba T; Department of Respiratory Medicine, Okinawa Chubu Hospital, Uruma, Okinawa, Japan.
Sakamoto K; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Hamada N; Graduate School of Medical Sciences, Kyushu University, Research Institute for Diseases of the Chest, Fukuoka, Japan.
Kuwano K; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Nakayama M; Department of Internal Medicine, Division of Pulmonary Medicine, Jichi Medical University, Shimono, Tochigi, Japan.
Ebina M; Department of Respiratory Medicine, Tohoku Medical and Pharmaceutical University Medical School, Sendai, Miyagi, Japan.
Enomoto N; Department of Internal Medicine, Second Division, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Atsumi K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Izumi S; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Tanino Y; Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Ishii H; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Ohnishi H; Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan.
Suda T; Department of Internal Medicine, Second Division, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 22; Vol. 13 (1), pp. 13664. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/therapy
Asthma*
Humans ; Cohort Studies ; Retrospective Studies ; Prognosis ; Prospective Studies ; Oxygen/therapeutic use
SCR Disease Name:
Pulmonary Disease, Chronic Obstructive, Severe Early-Onset
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force.
Autorzy:
Tanaka H; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Chubachi S; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Namkoong H; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Sato Y; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Asakura T; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Lee H; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Azekawa S; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Otake S; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Nakagawara K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Fukushima T; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Watase M; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Sakurai K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Kusumoto T; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Kondo Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Masaki K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Kamata H; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Ishii M; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Ueda S; JCHO (Japan Community Health Care Organization) Saitama Medical Center, Internal Medicine, Saitama, Japan.
Sasaki M; JCHO (Japan Community Health Care Organization) Saitama Medical Center, Internal Medicine, Saitama, Japan.
Izumo T; Japanese Red Cross Medical Center, Tokyo, Japan.
Inomata M; Japanese Red Cross Medical Center, Tokyo, Japan.
Miyazawa N; Department of Respiratory Medicine, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
Kimura Y; Department of Respiratory Medicine, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
Suzuki Y; Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Harada N; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
Ichikawa M; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
Takata T; Department of Infection Control, Fukuoka University Hospital, Fukuoka, Japan.
Ishikura H; Department of Emergency and Critical Care Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Yoshiyama T; Fukujuji Hospital, Kiyose, Japan.
Kokuto H; Fukujuji Hospital, Kiyose, Japan.
Murakami K; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Sano H; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ueda T; Department of Respiratory Medicine, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
Kuwahara N; Internal Medicine, Internal Medicine Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Fujiwara A; Internal Medicine, Internal Medicine Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Ogura T; Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Inoue T; Internal Medicine, Sano Kosei General Hospital, Sano, Japan.
Asami T; Internal Medicine, Sano Kosei General Hospital, Sano, Japan.
Mutoh Y; Department of Infectious Diseases, Tosei General Hospital, Seto, Japan.
Nakachi I; Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.
Baba R; Department of Infectious Diseases, Tosei General Hospital, Seto, Japan.
Nishi K; Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Tani M; Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Kagyo J; Keiyu Hospital, Yokohama, Japan.
Hashiguchi M; Keiyu Hospital, Yokohama, Japan.
Oguma T; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Asano K; Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Japan.
Nishikawa M; Department of Respiratory Medicine, Fujisawa City Hospital, Fujisawa, Japan.
Watanabe H; Department of Respiratory Medicine, Fujisawa City Hospital, Fujisawa, Japan.
Okada Y; Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan.; Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.; Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Koike R; Medical Innovation Promotion Center, Tokyo Medical and Dental University, Tokyo, Japan.
Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
Kimura A; Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.
Imoto S; Division of Health Medical Intelligence, Human Genome Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
Miyano S; M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Kanai T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Fukunaga K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Jun 08; Vol. 10 (7), pp. ofad311. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful tepotinib treatment of adenocarcinoma with MET exon 14 skipping and discordant results between Oncomine Dx target test and ArcherMET: A case report.
Autorzy:
Onodera Y; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Yamada S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Tabata E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Kitamura H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Komatsu S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Okudela K; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236-0051, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2023 May 09; Vol. 18 (6), pp. 49. Date of Electronic Publication: 2023 May 09 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase.
Autorzy:
Okuda R; Departments of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, Japan. .
Takemura T; Departments of Pathology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, 236-0051, Japan.
Iwasawa T; Departments of Radiology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, 236-0051, Japan.
Kaburaki S; Departments of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, Japan.
Baba T; Departments of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, Japan.
Hagiwara E; Departments of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, Japan.
Ogura T; Departments of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-Higashi, Kanazawa-Ku, Yokohama, Japan.
Pokaż więcej
Źródło:
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2022 Dec 09; Vol. 18 (1), pp. 104. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Automatic Deep-Learning-Based Lung Analysis on Quantification of Interstitial Lung Disease: Correlation with Pulmonary Function Test Results and Prognosis.
Autorzy:
Aoki R; Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.; Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Kanagawa, Japan.
Iwasawa T; Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.; Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Kanagawa, Japan.
Saka T; Kanazawa Institute of Technology, 7-1 Ohgigaoka, Nonoichi 921-8501, Ishikawa, Japan.
Yamashiro T; Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.
Utsunomiya D; Diagnostic Radiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.
Misumi T; Department of Biostatistics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Kanagawa, Japan.
Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Kanagawa, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Kanagawa, Japan.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Dec 04; Vol. 12 (12). Date of Electronic Publication: 2022 Dec 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
Autorzy:
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Naito T; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Shizuoka 411-8777, Japan.
Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, 2-15-3, Kawagishi-cho, Chuo-Ku, Niigata 951-8566, Japan.
Ito K; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka 515-0073, Japan.
Furuya N; Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Kawasaki 216-8511, Japan.
Misumi T; Department of Data Science, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa 277-8577, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama 241-8515, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 05; Vol. 14 (19). Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Conversion of Superoxide to Hydroperoxide on Cobalt(III) Depends on the Structural and Electronic Properties of Azole-Based Chelating Ligands.
Autorzy:
Nishiura T; Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa-ku, Yokohama 221-8686, Japan.
Ohta T; Department of Life Science, University of Hyogo, Ako-gun, Hyogo 678-1297, Japan.
Ogura T; Department of Life Science, University of Hyogo, Ako-gun, Hyogo 678-1297, Japan.
Nakazawa J; Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa-ku, Yokohama 221-8686, Japan.
Okamura M; Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa-ku, Yokohama 221-8686, Japan.
Hikichi S; Department of Material and Life Chemistry, Faculty of Engineering, Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa-ku, Yokohama 221-8686, Japan.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Sep 28; Vol. 27 (19). Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Cobalt*/chemistry
Superoxides*
Azoles ; Borates ; Boron ; Crystallography, X-Ray ; Electronics ; Hydrogen Peroxide ; Ligands ; Oxidoreductases ; Oxygenases ; Protons ; Trifluoroacetic Acid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy.
Autorzy:
Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Matama G; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Tabata E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Oda T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Okuda R; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Kitamura H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Satoh H; Department of Internal Medicine, Mito Medical Center, University of Tsukuba, Mito, Japan.
Misumi T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
Komatsu S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Iwasawa T; Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Sep; Vol. 13 (17), pp. 2443-2449. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/chemically induced
Lung Diseases, Interstitial*/pathology
Lung Neoplasms*/drug therapy
Aged ; Disease Progression ; Female ; Humans ; Male ; Prognosis ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of linezolid, rifampicin, and clindamycin combination therapy in patients with prosthetic joint infection.
Autorzy:
Kobayashi S; Department of Pharmacy, Nissan Tamagawa Hospital, Tokyo, Japan.
Tagawa S; Department of Pharmacy, Nissan Tamagawa Hospital, Tokyo, Japan.
Ogura T; Department of Pharmacy, Nissan Tamagawa Hospital, Tokyo, Japan.
Kitaoka A; Department of Pharmacy, Nissan Tamagawa Hospital, Tokyo, Japan.
Yasu T; Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Tokyo, Japan.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2022 Jul 20; Vol. 16 (3), pp. 142-144. Date of Electronic Publication: 2022 Jun 25.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia*/chemically induced
Anemia*/drug therapy
Arthritis, Infectious*
Hyponatremia*/chemically induced
Hyponatremia*/drug therapy
Neutropenia*/chemically induced
Neutropenia*/drug therapy
Anti-Bacterial Agents/adverse effects ; Clindamycin/adverse effects ; Humans ; Linezolid/adverse effects ; Rifampin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia.
Autorzy:
Kataoka T; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Okudela K; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Matsumura M; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Baba T; Division of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Kitamura H; Division of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Arai H; Division of Surgery, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Suzuki T; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Koike C; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Mutsui H; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Sekiya M; Division of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Sugiyama M; Division of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Takemura T; Division of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Iwasawa T; Division of Radiology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Ogura T; Division of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Ohashi K; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.; Department of Human Pathology, Graduate School and Faculty of Medicine, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2022 May 26; Vol. 24 (1), pp. 225. Date of Electronic Publication: 2022 May 26 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment.
Autorzy:
Mizukami T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Hamaji K; Department of Pharmacy, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Onuki R; Department of Pharmacy, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Yokomizo A; Department of Pharmacy, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Nagashima Y; Nutrition Unit, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Takeda H; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Umemoto K; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Doi A; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Arai H; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Hirakawa M; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Horie Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Izawa N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Ogura T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Tsuda T; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Sunakawa Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Shibata M; Nutrition Unit, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Tanaka T; Department of Pharmacy, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Mikami S; Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Nakajima TE; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy, Kyoto University Hospital, Kyoto, Japan.
Pokaż więcej
Źródło:
Nutrition and cancer [Nutr Cancer] 2022; Vol. 74 (2), pp. 539-545. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrectomy*
Stomach Neoplasms*/pathology
Weight Loss*
Aged ; Chemotherapy, Adjuvant ; Female ; Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic impact of HNF4α expression in interstitial lung disease.
Autorzy:
Sawazumi T; Division of Pathology, Yokohama City University Medical Center Hospital, Yokohama, Japan.; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Baba T; Division of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Iwasawa T; Division of Radiology, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Arai H; Division of General Thoracic Surgery, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Matsumura M; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takemura T; Division of Pathology, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Sugiyama M; Division of Pathology, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Sekiya M; Division of Pathology, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Saigusa Y; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ogura T; Division of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center Hospital, Yokohama, Japan.
Inayama Y; Division of Pathology, Yokohama City University Medical Center Hospital, Yokohama, Japan.
Ohashi K; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Okudela K; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2022 Jan; Vol. 72 (1), pp. 25-34. Date of Electronic Publication: 2021 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/pathology
Prognosis*
Hepatocyte Nuclear Factor 4/*metabolism
Aged ; Alveolar Epithelial Cells/metabolism ; Alveolar Epithelial Cells/pathology ; Biomarkers/metabolism ; Disease Progression ; Female ; Humans ; Idiopathic Pulmonary Fibrosis/diagnosis ; Idiopathic Pulmonary Fibrosis/pathology ; Lung/pathology ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.
Autorzy:
Miyakawa K; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kubo S; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Stanleyraj Jeremiah S; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Go H; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Yamaoka Y; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Kanagawa, Japan.
Ohtake N; Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.; Bioscience Division, Research and Development Department, Tosoh Corporation, Tokyo Research Center, Kanagawa, Japan.
Kato H; Infection Prevention and Control Department, Yokohama City University Hospital, Kanagawa, Japan.
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
Mihara T; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Kanagawa, Japan.
Matsuba I; Matsuba Medical Clinic, Kanagawa, Japan.
Sanno N; Shinagawa Strings Clinic, Tokyo, Japan.
Miyakawa M; Miyakawa Internal Medicine and Pediatrics Clinic, Kanagawa, Japan.; Japan Medical Association, Tokyo, Japan.
Shinkai M; Division of Internal Medicine, Tokyo-Shinagawa Hospital, Tokyo, Japan.
Miyazaki T; Department of Physiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
Ito S; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kaneko T; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Yamamoto K; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Goto A; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Kanagawa, Japan.
Ryo A; Department of Microbiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 10; Vol. 9 (2), pp. ofab626. Date of Electronic Publication: 2021 Dec 10 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.
Autorzy:
Shinkai M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Tsushima K; Department of Pulmonary Medicine, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba, 286-8520, Japan.
Tanaka S; Department of Otolaryngology, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya-ku, Tokyo, 154-8532, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Tarumoto N; Department of Infectious Disease and Infection control, Saitama Medical University Hospital, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Kawada I; Division of Pulmonary Medicine, Department of Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hirai Y; Department of Infectious Diseases, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachioji, Tokyo, 193-0998, Japan.
Fujiwara S; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Komase Y; Department of Respiratory Internal Medicine, St. Marianna University Yokohama City Seibu Hospital, 1197-1 Yasashi-cho, Asahi-ku, Yokohama, Kanagawa, 241-0811, Japan.
Saraya T; Department of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Koh H; Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, 4-2-22 Nishiki-cho, Tachikawa, Tokyo, 190-8531, Japan.
Kagiyama N; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, 1696 Itai, Kumagaya, Saitama, 360-0197, Japan.
Shimada M; Department of General Internal Medicine, Tokai University Oiso Hospital, 21-1 Gakkyo, Oiso-machi, Naka-gun, Kanagawa, 259-0198, Japan.
Kanou D; Department of Respiratory Internal Medicine, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kohoku-ku, Yokohama, Kanagawa, 222-0036, Japan.
Antoku S; Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, 2-24-18 Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan.
Uchida Y; Department of General Medicine, Kitakyushu Municipal Medical Center, 2-1-1 Bashaku, Kokurakita-ku, Kitakyushu, Fukuoka, 802-8561, Japan.
Tokue Y; Infection Control and Prevention Center, Gunma University Hospital, 3-39-15 Showamachi, Maebashi, Gunma, 371-8511, Japan.
Takamori M; Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8524, Japan.
Gon Y; Department of Respiratory Medicine, Nihon University Itabashi Hospital, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.
Ie K; Department of General Internal Medicine, Kawasaki Municipal Tama Hospital, 1-30-37 Shukugawara, Tama-ku, Kawasaki, Kanagawa, 214-8525, Japan.
Yamazaki Y; Department of Respiratory and Infectious Diseases, Nagano Prefectural Shinshu Medical Center, 1332 Suzaka, Suzaka, Nagano, 382-8577, Japan.
Harada K; Department of Cardiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
Miyao N; Department of Internal Medicine, Nippon Koukan Hospital, 1-2-1 Kokandori, Kawasaki-ku, Kawasaki, Kanagawa, 210-0852, Japan.
Naka T; Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.
Iwata M; Department of Emergency and General Internal Medicine, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Nakagawa A; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Hiyama K; Department of Infectious Diseases, National Hospital Organization Fukuokahigashi Medical Center, 1-1-1 Chidori, Koga, Fukuoka, 811-3195, Japan.
Ogawa Y; Department of Infectious Diseases, Sakai City Medical Center, 1-1-1 Ebarajicho, Nishi-ku, Sakai, Osaka, 593-8304, Japan.
Shinoda M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Ota S; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Hirouchi T; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Terada J; Department of Pulmonary Medicine, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba, 286-8520, Japan.
Kawano S; Department of Internal Medicine, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya-ku, Tokyo, 154-8532, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Sakurai T; Scientific Information Department, FujiFilm Toyama Chemical Co., Ltd., 3-4-8 Hatchobori, Chuo-ku, Tokyo, 104-0032, Japan.
Matsumoto Y; Scientific Information Department, FujiFilm Toyama Chemical Co., Ltd., 3-4-8 Hatchobori, Chuo-ku, Tokyo, 104-0032, Japan.
Kunishima H; Department of Infectious Diseases, School of Medicine, St. Marianna University, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Kobayashi O; Department of Infectious Diseases, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Iwata S; Department of Infectious Diseases, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .
Pokaż więcej
Źródło:
Infectious diseases and therapy [Infect Dis Ther] 2021 Dec; Vol. 10 (4), pp. 2489-2509. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.
Autorzy:
Kimura Y; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Nakai Y; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Shin J; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Hara M; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Takeda Y; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Kubo S; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.; Department of Pulmonology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Jeremiah SS; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Ino Y; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Akiyama T; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Moriyama K; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan.
Sakai K; School of Medicine Medical Course Emergency Medicine, Yokohama City University, Yokohama, 236-0004, Japan.
Saji R; School of Medicine Medical Course Emergency Medicine, Yokohama City University, Yokohama, 236-0004, Japan.
Nishii M; School of Medicine Medical Course Emergency Medicine, Yokohama City University, Yokohama, 236-0004, Japan.
Kitamura H; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, 236-0051, Japan.
Murohashi K; Department of Pulmonology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, 236-0051, Japan.
Yamamoto K; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Kaneko T; Department of Pulmonology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Takeuchi I; School of Medicine Medical Course Emergency Medicine, Yokohama City University, Yokohama, 236-0004, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, 236-0051, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, 236-0051, Japan.
Hasegawa H; Influenza Research Center, National Institute of Infectious Diseases, Musashimurayama, Tokyo, 208-0011, Japan.
Tamura T; Department of Immunology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Yamanaka T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan.
Ryo A; Advanced Medical Research Center, Yokohama City University, Yokohama, 236-0004, Japan. .; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Oct 19; Vol. 11 (1), pp. 20638. Date of Electronic Publication: 2021 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Profiling*
Biomarkers/*blood
COVID-19/*blood
COVID-19 Serological Testing/*methods
Proteomics/*methods
Chitinase-3-Like Protein 1/metabolism ; Enzyme-Linked Immunosorbent Assay ; Gas Chromatography-Mass Spectrometry ; Gene Expression Regulation ; Humans ; Inflammation ; Interleukin-1beta/biosynthesis ; Interleukin-6/biosynthesis ; Prognosis ; SARS-CoV-2 ; Tumor Necrosis Factor-alpha/biosynthesis ; Virus Diseases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD).
Autorzy:
Yamakawa H; Department of Respiratory Medicine, Saitama Red Cross Hospital, 1-5 Shintoshin, Chuo-ku, Saitama 330-8553, Japan.; Department of Internal Medicine, Division of Respiratory Diseases, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Kameda H; Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Toho University, 2-22-36 Ohashi, Meguro-ku, Tokyo 153-8515, Japan.
Kishaba T; Department of Respiratory Medicine, Okinawa Chubu Hospital, Okinawa, 81 Miyazato, Uruma 904-2293, Japan.
Iwasawa T; Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Takemura T; Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Kuwano K; Department of Internal Medicine, Division of Respiratory Diseases, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Aug 25; Vol. 10 (17). Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia.
Autorzy:
Ikeda S; Kanagawa Cardiovascular and Respiratory Center, Department of Respiratory Medicine, 6-16-1, Tomioka-higashi, Kanazawa-ku, Kanagawa 236-0051, Japan.
Kato T; Kanagawa Cancer Center, Department of Thoracic Oncology, 2-3-2, Nakao, Asahi-ku, Kanagawa 241-8515, Japan.
Kenmotsu H; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Shizuoka 411-8777, Japan.
Sekine A; Kanagawa Cardiovascular and Respiratory Center, Department of Respiratory Medicine, 6-16-1, Tomioka-higashi, Kanazawa-ku, Kanagawa 236-0051, Japan.
Baba T; Kanagawa Cardiovascular and Respiratory Center, Department of Respiratory Medicine, 6-16-1, Tomioka-higashi, Kanazawa-ku, Kanagawa 236-0051, Japan.
Ogura T; Kanagawa Cardiovascular and Respiratory Center, Department of Respiratory Medicine, 6-16-1, Tomioka-higashi, Kanazawa-ku, Kanagawa 236-0051, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 06; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 06.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 70

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies